Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 578

1.

Evaluation One Year after DAIR Treatment in 91 Suspected Early Prosthetic Joint Infections in Primary Knee and Hip Arthroplasty.

Jacobs AME, Valkering LJJ, Bénard M, Meis JF, Goosen JHM.

J Bone Jt Infect. 2019 Oct 15;4(5):238-244. doi: 10.7150/jbji.37757. eCollection 2019.

2.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group.

Lancet Infect Dis. 2019 Nov 4. pii: S1473-3099(19)30312-3. doi: 10.1016/S1473-3099(19)30312-3. [Epub ahead of print] Review.

PMID:
31699664
3.

Thermogenic Characterization and Antifungal Susceptibility of Candida auris by Microcalorimetry.

Di Luca M, Koliszak A, Karbysheva S, Chowdhary A, Meis JF, Trampuz A.

J Fungi (Basel). 2019 Nov 6;5(4). pii: E103. doi: 10.3390/jof5040103.

4.

Ongoing Challenges with Healthcare-Associated Candida auris Outbreaks in Oman.

Al Maani A, Paul H, Al-Rashdi A, Wahaibi AA, Al-Jardani A, Al Abri AMA, AlBalushi MAH, Abri SA, Al Reesi M, Al Maqbali A, Al Kasaby NM, de Groot T, Meis JF, Al-Hatmi AMS.

J Fungi (Basel). 2019 Oct 23;5(4). pii: E101. doi: 10.3390/jof5040101.

5.

External Quality Assessment Evaluating the Ability of Dutch Clinical Microbiological Laboratories to Identify Candida auris.

Buil JB, van der Lee HAL, Curfs-Breuker I, Verweij PE, Meis JF.

J Fungi (Basel). 2019 Oct 7;5(4). pii: E94. doi: 10.3390/jof5040094.

6.

The First Two Cases of Candida auris in The Netherlands.

Vogelzang EH, Weersink AJL, van Mansfeld R, Chow NA, Meis JF, van Dijk K.

J Fungi (Basel). 2019 Sep 30;5(4). pii: E91. doi: 10.3390/jof5040091.

7.

A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile.

Singh A, Masih A, Monroy-Nieto J, Singh PK, Bowers J, Travis J, Khurana A, Engelthaler DM, Meis JF, Chowdhary A.

Fungal Genet Biol. 2019 Sep 3;133:103266. doi: 10.1016/j.fgb.2019.103266. [Epub ahead of print]

PMID:
31491507
8.

cyp51A Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex.

Talbot JJ, Frisvad JC, Meis JF, Hagen F, Verweij PE, Hibbs DE, Lai F, Groundwater PW, Samson RA, Kidd SE, Barrs VR, Houbraken J.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e00632-19. doi: 10.1128/AAC.00632-19. Print 2019 Nov.

9.

Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting.

Kenters N, Kiernan M, Chowdhary A, Denning DW, Pemán J, Saris K, Schelenz S, Tartari E, Widmer A, Meis JF, Voss A.

Int J Antimicrob Agents. 2019 Oct;54(4):400-406. doi: 10.1016/j.ijantimicag.2019.08.013. Epub 2019 Aug 13.

PMID:
31419480
10.

In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species.

Mahmoudi S, Rezaie S, Daie Ghazvini R, Hashemi SJ, Badali H, Foroumadi A, Diba K, Chowdhary A, Meis JF, Khodavaisy S.

Mycopathologia. 2019 Oct;184(5):607-613. doi: 10.1007/s11046-019-00370-7. Epub 2019 Aug 10.

PMID:
31401757
11.

Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.

Colley T, Sharma C, Alanio A, Kimura G, Daly L, Nakaoki T, Nishimoto Y, Bretagne S, Kizawa Y, Strong P, Rapeport G, Ito K, Meis JF, Chowdhary A.

J Antimicrob Chemother. 2019 Oct 1;74(10):2950-2958. doi: 10.1093/jac/dkz302.

12.

Potential Fifth Clade of Candida auris, Iran, 2018.

Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF.

Emerg Infect Dis. 2019 Sep;25(9):1780-1781. doi: 10.3201/eid2509.190686. Epub 2019 Sep 17.

13.

ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studies.

Koehler P, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bretagne S, Klingspor L, Lagrou K, Meis JF, Rautemaa-Richardson R, Schelenz S, Hamprecht A, Koehler FC, Kurzai O, Salmanton-García J, Vehreschild JJ, Alanio A, Alastruey-Izquierdo A, Arsic Arsenijevic V, Gangneux JP, Gow NAR, Hadina S, Hamal P, Johnson E, Klimko N, Lass-Flörl C, Mares M, Özenci V, Papp T, Roilides E, Sabino R, Segal E, Talento AF, Tortorano AM, Verweij PE, Hoenigl M, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2019 Oct;62(10):920-927. doi: 10.1111/myc.12963. Epub 2019 Aug 1.

PMID:
31271702
14.

Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management.

Rudramurthy SM, Paul RA, Chakrabarti A, Mouton JW, Meis JF.

J Fungi (Basel). 2019 Jul 1;5(3). pii: E55. doi: 10.3390/jof5030055. Review.

15.

Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 Deficiency.

Queiroz-Telles F, Mercier T, Maertens J, Sola CBS, Bonfim C, Lortholary O, Constantino-Silva RMN, Schrijvers R, Hagen F, Meis JF, Herkert PF, Breda GL, França JB, Filho NAR, Lanternier F, Casanova JL, Puel A, Grumach AS.

J Clin Immunol. 2019 Jul;39(5):462-469. doi: 10.1007/s10875-019-00662-z. Epub 2019 Jun 20.

PMID:
31222666
16.

A simple and low cost tetra-primer ARMS-PCR method for detection triazole-resistant Aspergillus fumigatus.

Mahmoudi S, Badali H, Rezaie S, Azarnezhad A, Barac A, Kord M, Ahmadikia K, Aala F, Ali Askari F, Meis JF, Khodavaisy S.

Mol Biol Rep. 2019 Aug;46(4):4537-4543. doi: 10.1007/s11033-019-04909-1. Epub 2019 Jun 18.

PMID:
31214961
17.

Does Online Search Behavior Coincide with Candida auris Cases? An Exploratory Study.

Saris K, Meis JF, Baño JR, Tacconelli E, van de Belt TH, Voss A.

J Fungi (Basel). 2019 Jun 4;5(2). pii: E44. doi: 10.3390/jof5020044.

18.

Brazil is so far free from Candida auris. Are we missing something?

Pasqualotto AC, Sukiennik TCT, Meis JF.

Braz J Infect Dis. 2019 May - Jun;23(3):149-150. doi: 10.1016/j.bjid.2019.05.004. Epub 2019 May 29. No abstract available.

19.

Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen.

Dal Mas C, Rossato L, Shimizu T, Oliveira EB, da Silva Junior PI, Meis JF, Colombo AL, Hayashi MAF.

Biomolecules. 2019 May 28;9(6). pii: E205. doi: 10.3390/biom9060205.

20.

Nonrandom Distribution of Azole Resistance across the Global Population of Aspergillus fumigatus.

Sewell TR, Zhu J, Rhodes J, Hagen F, Meis JF, Fisher MC, Jombart T.

MBio. 2019 May 21;10(3). pii: e00392-19. doi: 10.1128/mBio.00392-19.

21.

In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra.

Badali H, Al-Hatmi AMS, Fakhim H, Moghaddasi A, Khodavaisy S, Vaezi A, Ahangarkani F, de Hoog GS, Meis JF.

Int J Antimicrob Agents. 2019 Jul;54(1):95-98. doi: 10.1016/j.ijantimicag.2019.05.006. Epub 2019 May 7.

PMID:
31071468
22.

One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.

Lavergne RA, Morio F, Danner-Boucher I, Horeau-Langlard D, David V, Hagen F, Meis JF, Le Pape P.

J Antimicrob Chemother. 2019 Jul 1;74(7):1884-1889. doi: 10.1093/jac/dkz144.

PMID:
31038164
23.

Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil.

Herkert PF, Al-Hatmi AMS, de Oliveira Salvador GL, Muro MD, Pinheiro RL, Nucci M, Queiroz-Telles F, de Hoog GS, Meis JF.

Front Microbiol. 2019 Apr 10;10:737. doi: 10.3389/fmicb.2019.00737. eCollection 2019.

24.

Microsatellite Stability in STR Analysis Aspergillus fumigatus Depends on Number of Repeat Units.

de Groot T, Meis JF.

Front Cell Infect Microbiol. 2019 Mar 29;9:82. doi: 10.3389/fcimb.2019.00082. eCollection 2019.

25.

Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America.

Alvarez-Moreno C, Lavergne RA, Hagen F, Morio F, Meis JF, Le Pape P.

Mycologia. 2019 Mar-Apr;111(2):217-224. doi: 10.1080/00275514.2018.1557796. Epub 2019 Mar 21.

PMID:
30896313
26.

Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS.

Vatanshenassan M, Boekhout T, Meis JF, Berman J, Chowdhary A, Ben-Ami R, Sparbier K, Kostrzewa M.

Front Cell Infect Microbiol. 2019 Feb 18;9:20. doi: 10.3389/fcimb.2019.00020. eCollection 2019.

27.

Candida auris in an Intensive Care Setting.

Meis JF, Voss A.

N Engl J Med. 2019 Feb 28;380(9):890-891. doi: 10.1056/NEJMc1900112. No abstract available.

PMID:
30811923
28.

Extensive tinea capitis and corporis in a child caused by Trichophyton verrucosum.

Jiang Y, Zhan P, Al-Hatmi AMS, Shi G, Wei Y, van den Ende AHGG, Meis JF, Lu H, de Hoog GS.

J Mycol Med. 2019 Apr;29(1):62-66. doi: 10.1016/j.mycmed.2019.01.007. Epub 2019 Feb 22.

PMID:
30799183
29.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1704-1712. doi: 10.1093/jac/dkz051.

PMID:
30770712
30.

Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.

Singh A, Singh PK, de Groot T, Kumar A, Mathur P, Tarai B, Sachdeva N, Upadhyaya G, Sarma S, Meis JF, Chowdhary A.

J Antimicrob Chemother. 2019 May 1;74(5):1260-1268. doi: 10.1093/jac/dkz029.

PMID:
30753525
31.

Killing of Candida auris by UV-C: Importance of exposure time and distance.

de Groot T, Chowdhary A, Meis JF, Voss A.

Mycoses. 2019 May;62(5):408-412. doi: 10.1111/myc.12903. Epub 2019 Mar 12.

PMID:
30748018
32.

A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit.

Rozaliyani A, Sedono R, Jusuf A, Rumende CM, Aniwidyaningsih W, Burhan E, Prasenohadi P, Handayani D, Yunihastuti E, Siagian FE, Jayusman AM, Rusli A, Sungkar S, Prihartono J, Hagen F, Meis JF, Wahyuningsih R.

Saudi Med J. 2019 Feb;40(2):140-146. doi: 10.15537/smj.2019.2.22940.

33.

High-resolution fingerprinting of Candida parapsilosis isolates suggests persistence and transmission of infections among neonatal intensive care unit patients in Kuwait.

Asadzadeh M, Ahmad S, Al-Sweih N, Hagen F, Meis JF, Khan Z.

Sci Rep. 2019 Feb 4;9(1):1340. doi: 10.1038/s41598-018-37855-2.

34.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

35.

Candida auris otomycosis in Iran and review of recent literature.

Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Taghizadeh Armaki M, Roodgari S, Kiakojuri K, Al-Hatmi AMS, Meis JF, Badali H.

Mycoses. 2019 Feb;62(2):101-105. doi: 10.1111/myc.12886. Review.

PMID:
30585653
36.

Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management.

Lestrade PPA, Meis JF, Melchers WJG, Verweij PE.

Clin Microbiol Infect. 2019 Jul;25(7):799-806. doi: 10.1016/j.cmi.2018.11.027. Epub 2018 Dec 21. Review.

PMID:
30580035
37.

Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus.

Arikan-Akdagli S, Ghannoum M, Meis JF.

J Fungi (Basel). 2018 Dec 5;4(4). pii: E129. doi: 10.3390/jof4040129. Review.

38.

An unusual case of gastrointestinal basidiobolomycosis mimicking colon cancer; literature and review.

Mohammadi R, Ansari Chaharsoghi M, Khorvash F, Kaleidari B, Sanei MH, Ahangarkani F, Abtahian Z, Meis JF, Badali H.

J Mycol Med. 2019 Apr;29(1):75-79. doi: 10.1016/j.mycmed.2018.11.004. Epub 2018 Dec 13. Review.

PMID:
30553627
39.

Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study.

Engel TGP, Slabbers L, de Jong C, Melchers WJG, Hagen F, Verweij PE, Merkus P, Meis JF; Dutch Cystic Fibrosis Fungal Collection Consortium.

J Cyst Fibros. 2019 Mar;18(2):221-226. doi: 10.1016/j.jcf.2018.11.012. Epub 2018 Dec 1.

PMID:
30514613
40.

Case report: A fatal case of cryptococcosis in an immunocompetent patient due to Cryptococcus deuterogattii (AFLP6/VGII).

Bauer M, Wickenhauser C, Haak A, Pazaitis N, Siebolts U, Mawrin C, Strauss C, Rickerts V, Stoevesandt D, Cornely OA, Meis JF, Hagen F.

JMM Case Rep. 2018 Oct 23;5(10):e005168. doi: 10.1099/jmmcr.0.005168. eCollection 2018 Oct.

41.

Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China.

Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F, Xiao M, Wang H, Barresi C, Zhou ML, de Hoog GS, Xu YC.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01505-18. doi: 10.1128/JCM.01505-18. Print 2019 Feb.

42.

ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait.

Ahmad S, Joseph L, Parker JE, Asadzadeh M, Kelly SL, Meis JF, Khan Z.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01900-18. doi: 10.1128/AAC.01900-18. Print 2019 Feb.

43.
44.

Genotyping of Aspergillus fumigatus in Formalin-Fixed Paraffin-Embedded Tissues and Serum Samples From Patients With Invasive Aspergillosis.

de Groot T, Hagen F, Vreuls W, Verweij PE, Chowdhary A, Meis JF.

Front Cell Infect Microbiol. 2018 Oct 23;8:377. doi: 10.3389/fcimb.2018.00377. eCollection 2018.

45.

Frequency and Geographic Distribution of CARD9 Mutations in Patients With Severe Fungal Infections.

Vaezi A, Fakhim H, Abtahian Z, Khodavaisy S, Geramishoar M, Alizadeh A, Meis JF, Badali H.

Front Microbiol. 2018 Oct 12;9:2434. doi: 10.3389/fmicb.2018.02434. eCollection 2018. Review.

46.

Perspectives on misidentification of Trichophyton interdigitale/Trichophyton mentagrophytes using internal transcribed spacer region sequencing: Urgent need to update the sequence database.

Chowdhary A, Singh A, Singh PK, Khurana A, Meis JF.

Mycoses. 2019 Jan;62(1):11-15. doi: 10.1111/myc.12865. Epub 2018 Nov 15. Review.

PMID:
30367553
47.

Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism.

Pakshir K, Fakhim H, Vaezi A, Meis JF, Mahmoodi M, Zomorodian K, Javidnia J, Ansari S, Hagen F, Badali H.

J Mycol Med. 2018 Dec;28(4):599-605. doi: 10.1016/j.mycmed.2018.09.005. Epub 2018 Oct 12.

PMID:
30322827
48.

Candida auris: a global fungal public health threat.

Meis JF, Chowdhary A.

Lancet Infect Dis. 2018 Dec;18(12):1298-1299. doi: 10.1016/S1473-3099(18)30609-1. Epub 2018 Oct 4. No abstract available.

PMID:
30293876
49.

Epidemiology of Aspergillus species causing keratitis in Mexico.

Al-Hatmi AMS, Castro MA, de Hoog GS, Badali H, Alvarado VF, Verweij PE, Meis JF, Zago VV.

Mycoses. 2019 Feb;62(2):144-151. doi: 10.1111/myc.12855. Epub 2018 Oct 14.

PMID:
30256460
50.

Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis.

Abastabar M, Haghani I, Shokohi T, Hedayati MT, Aghili SR, Jedi A, Dadashi S, Shabanzadeh S, Hosseini T, Aslani N, Meis JF, Badali H.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01632-18. doi: 10.1128/AAC.01632-18. Print 2018 Dec.

Supplemental Content

Support Center